Delaney S R, Conrad H E
Biochem J. 1983 Feb 1;209(2):315-22. doi: 10.1042/bj2090315.
Heparan sulphate by-products from the commercial manufacture of pig mucosal heparin were freed of chondroitin sulphate and fractionated according to anionic density. The fractions were treated with HNO2 at pH 1.5, and the resulting mixtures of oligosaccharides were reduced with NaB3H4 and analysed for their disaccharide composition by paper chromatography and by high-pressure liquid chromatography. The results show that the molar ratio of 2-O-sulpho-alpha-L-iduronosylanhydromannose to 6-O-sulpho-(2-O-sulpho-alpha-L-iduronosyl)anhydromannose decreased from 2.5 to 0.04 as the degree of sulphation of the fractions increased. In contrast, the molar ratio of 6-O-sulpho-(beta-D-glucuronosyl)anhydromannose to 6-O-sulpho-(alpha-L-iduronosyl)anhydromannose was approx. 2.4 in all heparan sulphate fractions and decreased to only half of this value in the most highly sulphated heparin fractions. These results are consistent with biosynthetic studies, which have shown that the N-sulpho-(2-O-sulpho-alpha-L-iduronosyl)D-glucosamine disaccharide is the metabolic precursor of the NO-disulpho-(2-O-sulpho-alpha-L-iduronosyl)-D-glucosamine disaccharide in heparin biosynthesis. The high-pressure liquid chromatography of the heparan sulphate oligosaccharides also revealed a number of unidentified oligosaccharides in the deamination mixtures.
从猪黏膜肝素商业生产中获得的硫酸乙酰肝素副产物去除了硫酸软骨素,并根据阴离子密度进行了分级分离。各分级产物在pH 1.5条件下用亚硝酸处理,所得寡糖混合物用硼氢化钠还原,然后通过纸色谱法和高压液相色谱法分析其二糖组成。结果表明,随着分级产物硫酸化程度的增加,2-O-磺基-α-L-艾杜糖醛酸基脱水甘露糖与6-O-磺基-(2-O-磺基-α-L-艾杜糖醛酸基)脱水甘露糖的摩尔比从2.5降至0.04。相比之下,6-O-磺基-(β-D-葡糖醛酸基)脱水甘露糖与6-O-磺基-(α-L-艾杜糖醛酸基)脱水甘露糖的摩尔比在所有硫酸乙酰肝素分级产物中约为2.4,而在硫酸化程度最高的肝素分级产物中仅降至该值的一半。这些结果与生物合成研究一致,生物合成研究表明,N-磺基-(2-O-磺基-α-L-艾杜糖醛酸基)D-葡糖胺二糖是肝素生物合成中NO-二磺基-(2-O-磺基-α-L-艾杜糖醛酸基)-D-葡糖胺二糖的代谢前体。硫酸乙酰肝素寡糖的高压液相色谱分析还揭示了脱氨混合物中有一些未鉴定的寡糖。